Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 105 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Φίλτρα: Συντάκτης is Katsiki, Niki  [Clear All Filters]
Journal Article
Gossios, T. D., Ziakas A., Doumas M., Katsiki N., Petroglou D., Kouparanis A., et al. (2014).  Renal denervation: transition from pathophysiology to clinical practice.. Angiology. 65(9), 760-8.
Athyros, V. G., Karagiannis A., Katsiki N., & Mikhailidis D. P. (2012).  Relation of improvement in glomerular filtration rate with atorvastatin to reductions in heart failure morbidity.. Am J Cardiol. 110(5), 763.
Mantelas, M., Katsiki N., Antonitsis P., Kyurdzhieva E., Mikhailidis D. P., & Hatzitolios A. (2011).  Rectus sheath hematoma: a simplified emergency surgical approach.. Open Cardiovasc Med J. 5, 4-5.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  Reaching hypertriglyceridemia goals.. Curr Med Res Opin. 30(3), 391-3.
Doumas, M., Katsiki N., & Papademetriou V. (2018).  Psoriasis and Cardiovascular Disease: Two Sides of the Same Coin?. Angiology. 69(1), 5-9.
Stavropoulos, K., Imprialos K. P., Katsiki N., Petidis K., Kamparoudis A., Petras P., et al. (2018).  Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?. J Clin Hypertens (Greenwich). 20(5), 942-948.
Athyros, V. G., Katsiki N., Tziomalos K., & Karagiannis A. (2011).  Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role?. Open Cardiovasc Med J. 5, 226-30.
Athyros, V. G., Katsiki N., & Karagiannis A. (2013).  Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary intervention.. Circ J. 77(5), 1348.
Katsiki, N., Doumas M., Athyros V. G., & Karagiannis A. (2014).  Prehypertension and the cardiometabolic syndrome: targeting several risk factors to achieve maximum benefit.. Expert Rev Cardiovasc Ther. 12(3), 295-6.
Baltazi, M., Katsiki N., Savopoulos C., Iliadis F., Koliakos G., & Hatzitolios A. I. (2011).  Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study.. Am J Cardiovasc Dis. 1(1), 48-59.
Papanas, N., Katsiki N., Hatzitolios A. I., & Maltezos E. (2011).  Pioglitazone: a valuable component of combination therapy for type 2 diabetes mellitus.. Expert Opin Pharmacother. 12(10), 1457-61.
Upadhyay, J., Polyzos S. A., Perakakis N., Thakkar B., Paschou S. A., Katsiki N., et al. (2018).  Pharmacotherapy of type 2 diabetes: An update.. Metabolism. 78, 13-42.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  Peripheral artery disease in patients with type 2 diabetes.. J Diabetes Complications. 28(6), 912.
Katsiki, N., Hatzitolios A. I., & Mikhailidis D. P. (2011).  Passive smoking: the democratic right of nonsmokers to survive.. Angiology. 62(7), 520-2.
Athyros, V. G., Katsiki N., & Karagiannis A. (2016).  Off target effects of statins shape total mortality?. J Drug Assess. 5(1), 4-5.
Katsiki, N., Anagnostis P., Kotsa K., Goulis D. G., & Mikhailidis D. P. (2019).  Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus.. Curr Pharm Des. 25(18), 2051-2059.
Athyros, V. G., Tziomalos K., Katsiki N., & Mikhailidis D. P. (2014).  Novel data on the pathogenesis of atherosclerosis, treatment targets, and new therapeutic interventions in lipid-related cardiovascular risk factors.. Curr Pharm Des. 20(40), 6215-9.
Athyros, V. G., Polyzos S. A., Kountouras J., Katsiki N., Anagnostis P., Doumas M., et al. (2019).  Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block.. Curr Vasc Pharmacol.
Athyros, V. G., Katsiki N., & Karagiannis A. (2013).  Nonalcoholic fatty liver disease and severity of cardiovascular disease manifestations.. Angiology. 64(8), 572-5.
Katsiki, N., Hatzitolios A. I., & Mikhailidis D. P. (2011).  Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: 'a new kid on the block'?. Ann Med. 43(4), 249-58.
Katsiki, N., Athyros V. G., & Karagiannis A. (2014).  Metabolic syndrome in clinical practice.. Cardiol J. 21(2), 209.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  Metabolic syndrome and non-cardiac vascular diseases: an update from human studies.. Curr Pharm Des. 20(31), 4944-52.
Koumaras, C., Katsiki N., Athyros V. G., & Karagiannis A. (2013).  Metabolic syndrome and arterial stiffness: the past, the present and the future.. J Cardiovasc Med (Hagerstown). 14(10), 687-9.
Anagnostis, P., Paschou S. A., Katsiki N., Krikidis D., Lambrinoudaki I., & Goulis D. G. (2019).  Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?. Curr Vasc Pharmacol. 17(6), 564-572.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2012).  Managing the combination of non-alcoholic fatty liver disease and metabolic syndrome.. Expert Opin Pharmacother. 13(2), 287-8; author reply 289-90.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές